Sinusoidal Cells in Liver Injury and Repair

Hepatotoxicity: From Genomics to in vitro and in vivo Models

Volumn , Issue , 2008, Pages 341-370

  Gardner, Carol R ^a   Laskin, Debra L ^a  

^a RUTGERS UNIVERSITY   (United States)

Author keywords

Cytochrome P450 mediated metabolism; Endothelial cells and stellate cells; Hepatic sinusoidal cells; Hepatocyte growth factor; Hepatocyte protein and nucleic acid biosynthesis; Homeostatic conditions; Inflammatory cytotoxic cytokines; Normal liver architecture; Phagocytic leukocytes; Tumor necrosis factor (TNF )

Indexed keywords

EID: 84889451762     PISSN: None     EISSN: None     Source Type: Book    
DOI: 10.1002/9780470516751.ch13     Document Type: Chapter

References (300)

1. H.M. Mehendale, Tissue repair: an important determinant of final outcome of toxicant-induced injury. Toxicol. Pathol. 33, 41-51 (2005).
2. N. Kaplowitz, Drug-induced liver disorders: introduction and overvie, in Drug-Induced Liver Disease, 1st Edition, N. Kaplowitz and L.D. DeLeve (Eds), Marcel Dekker, New York, NY, USA, 2003, pp. 1-13.
3. D.L. Laskin and C.R. Gardner, Nonparenchymal cell, inflammatory macrophages and hepatotoxicity, in Drug-Induced Liver Disease, 1st Edition, N. Kaplowitz and L.D. DeLeve (Eds), Marcel Dekker, New York, NY, USA, 2003, pp. 183-211.
4. M.I. Luster, P.P. Simeonova, R. Gallucci and J. Matheson, Tumor necrosis factor alpha and toxicology. Crit. Rev. Toxicol. 29, 491-511 (1999).
5. R. Taub, M. Bansal and W. Lei, Roles of cytokines and growth factors in liver regeneratio, repair and fibrosis after liver injury, in Drug-Induced Liver Disease, 1st Edition, N. Kaplowitz and L.D. DeLeve (Eds), Marcel Dekker, New York, NY, USA, 2003, pp. 213-225.
6. R.M. Gallucci, P. Simeonova, W. Toriumi and M.I. Luster, TNF-α regulates transforming growth factor-alpha expression in regenerating murine liver and isolated hepatocytes. J. Immunol. 164, 872-878 (2000).
7. Y. Yamada and N. Fausto, Deficient liver regeneration after carbon tetrachloride injury in mice lacking type 1 but not type 2 tumor necrosis factor receptor. Am. J. Pathol. 152, 1577-1589 (1998).
8. L. Bouwens, M. Baekeland, R. De Zanger and E. Wisse, Quantitation, tissue distribution and proliferation kinetics of Kupffer cells in normal rat liver. Hepatology 6, 718-722 (1986).
9. N. Ahmad, C.R. Gardner, E.J. Yurkow and D.L. Laskin, Inhibition of macrophages with gadolinium chloride alters intercellular adhesion molecule-1 expression in the liver during acute endotoxemia in rats. Hepatology 29, 728-736 (1999).
10. I. Bykov, P. Ylipaasto, L. Eerola and K.O. Lindros, Phagocytosis and LPS-stimulated production of cytokines and prostaglandin E2 is different in Kupffer cells isolated from the periportal or perivenous liver region. Scand. J. Gastroenterol. 38, 1256-1261 (2003).
11. T.J. Caperna and J.S. Garvey, Antigen handling in aging. II. The role ofKupffer and endothelial cells in antigen processing in Fischer 344 rats. Mech. Ageing Dev. 20, 205-221 (1982).
12. C.R. Gardner, A.J. Wasserman and D.L. Laskin, Differential sensitivity of tumor targets to liver macrophage-mediated cytotoxicity. Cancer Res. 47, 6686-6691 (1987).
13. C.R. Gardner, A.J. Wasserman and D.L. Laskin, Liver macrophage mediated cytotoxicity involves phagocytosis of tumor targets. Hepatology 14, 318-324 (1991).
14. T. Gustot, A. Lemmers, C. Moreno, N. Nagy, E. Quertinmont, C. Nicaise, D. Franchimont, H. Louis, J. Deviere and O. Le Moine, Differential liver sensitization to toll-like receptor pathways in mice with alcoholic fatty liver. Hepatology 43, 989-1000 (2006).
15. K.Y. Helmy, K.J. Katschke, Jr, N.N. Gorgani, N.M. Kljavin, J.M. Elliott, L. Diehl, S.J. Scales, N. Ghilardi and M. van Lookeren Campagne, CRIg: a macrophage complement receptor required for phagocytosis of circulating pathogens. Cell 124, 915-927 (2006).
16. T. Løvdal, E. Andersen, A. Brech and T. Berg, Fc receptor mediated endocytosis of small soluble immunoglobulin G immune complexes in Kupffer cells and endothelial cells from rat liver. J. Cell Sci. 113, 3255-3266 (2000).
17. M. Naito, G. Hasegawa, Y. Ebe and T. Yamamoto, Differentiation and function of Kupffer cells. Med. Electron Microsc. 37, 16-28 (2004).
18. A.M. Pilaro and D.L. Laskin, Accumulation of activated mononuclear phagocytes in the liver following lipopolysaccharide treatment of rats. J. Leukoc. Biol. 40, 29-41 (1986).
19. G.A. Parker and C.A. Picut, Liver immunobiology. Toxicol. Pathol. 33, 52-62 (2005).
20. J. Shi, H. Fujieda, Y. Kokubo and K. Wake, Apoptosis of neutrophils and their elimination by Kupffer cells in rat liver. Hepatology 24, 1256-1263 (1996).
21. A. Sano, M.E. Taylor, M.S. Leaning and J.A. Summerfield, Uptake and processing of glycoproteins by isolated rat hepatic endothelial and Kupffer cells. J. Hepatol. 10, 211-216 (1990).
22. V. Terpstra and T.J. van Berkel, Scavenger receptors on liver Kupffer cells mediate the in vivo uptake of oxidatively damaged red blood cells in mice. Blood 95, 2157-2163 (2000).
23. M. van Oosten, E. van de Bilt, T.J. van Berkel and J. Kuiper, New scavenger receptor-like receptors for the binding of lipopolysaccharide to liver endothelial and Kupffer cells. Infect. Immun. 66, 5107-5112 (1998).
24. S. Yamashina, Y. Takei, K. Ikejima, N. Enomoto, T. Kitamura and N. Sato, Ethanol-induced sensitization to endotoxin in Kupffer cells is dependent upon oxidative stress. Alcohol Clin. Exp. Res. 29, 246S-250S (2005).
25. G. Zuo, J. Gong, C. Liu, C. Wu, S. Li and L. Dai, Synthesis of Toll-like receptor 4 in Kupffer cells and its role in alcohol-induced liver disease. Chin. Med. J. (Engl.) 116, 297-300 (2003).
26. D.L. Laskin and A.M. Pilaro, Potential role of activated macrophages in acetaminophen hepatotoxicity. I. Isolation and characterization of activated macrophages from rat liver. Toxicol. Appl. Pharmacol. 86, 204-215 (1986).
27. T.W. McCloskey, J.A. Todaro and D.L. Laskin, Lipopolysaccharide treatment of rats alters antigen expression and oxidative metabolism in hepatic macrophages and endothelial cells. Hepatology 16, 191-203 (1992).
28. P. Liu, G.M. McGuire, M.A. Fisher, A. Farhood, C.W. Smith and H. Jaeschke, Activation of Kupffer cells and neutrophils for reactive oxygen formation is responsible for endotoxinenhanced liver injury after hepatic ischemia. Shock 3, 56-62 (1995).
29. D.L. Laskin, D.E. Heck, C.R. Gardner, L.S. Feder and J.D. Laskin, Distinct patterns of nitric oxide production in hepatic macrophages and endothelial cells following acute exposure of rats to endotoxin. J. Leukoc. Biol. 56, 751-758 (1994).
30. D.L. Laskin, Xenobiotic-induced inflammation and injury in the liver, in Hepatic and Gastrointestinal Toxicology, R.S. McCuskey and D.L. Earnest (Eds), Pergamon Press, New York, NY, USA, 1997, pp. 151-164.
31. A. Tanner, A. Keyhani, R. Reiner, G. Holdstock and R. Wright, Proteolytic enzymes released by liver macrophages may promote injury in a rat model of hepatic damage. Gastroenterology 80, 647-654 (1981).
32. K. Decker, Biologically active products of stimulated liver macrophages (Kupffer cells). Eur. J. Biochem. 192, 245-261 (1990).
33. M.K. Dahle, G.Overland, A.E. Myhre, J.F. Stuestol,T. Hartung, C.D. Krohn, O. Mathiesen, J.E. Wang and A.O. Aasen, The phosphatidylinositol 3-kinase/protein kinase B signaling pathway is activated by lipoteichoic acid and plays a role in Kupffer cell production of interleukin-6 (IL-6) and IL-10. Infect. Immun. 72, 5704-5711 (2004).
34. L.S. Feder, J.A. Todaro and D.L. Laskin, Characterization of interleukin-1 and interleukin-6 production by hepatic endothelial cells and macrophages. J. Leukoc. Biol. 53, 126-132 (1993).
35. H. Tsutsui, K. Matsui, H. Okamura and K. Nakanishi, Pathophysiological roles of interleukin-18 in inflammatory liver diseases. Immunol. Rev. 174, 192-209 (2000).
36. H. Tsutsui, K. Adachi, E. Seki and K. Nakanishi, Cytokine-induced inflammatory liver injuries. Curr. Mol. Med. 3, 545-559 (2003).
37. Y. Kojima, S. Suzuki, Y. Tsuchiya, H. Konno, S. Baba and S. Nakamura, Regulation of pro-inflammatory and anti-inflammatory cytokine responses by Kupffer cells in endotoxinenhanced reperfusion injury after total hepatic ischemia. Transpl. Int. 16, 231-240 (2003).
38. L.S. Feder and D.L. Laskin, Regulation of hepatic endothelial cell and macrophage proliferation and nitric oxide production by GM-CSF, M-CSF and IL-1β following acute endotoxemia. J. Leukoc. Biol. 55, 507-513 (1994).
39. S. Noji, K. Tashiro, E. Koyama, T. Nohno, K. Ohyama, S. Taniguchi and T. Nakamura, Expression of hepatocyte growth factor gene in endothelial and Kupffer cells of damaged rat livers, as revealed by in situ hybridization. Biochem. Biophys. Res. Commun. 173, 42-47 (1990).
40. T. Takeishi, K. Hirano, T. Kobayashi, G. Hasegawa, K. Hatakeyama and M. Naito, The role of Kupffer cells in liver regeneration. Arch. Histol. Cytol. 62, 413-422 (1999).
41. S. Roth,W. Gong and A.M. Gressner, Expression of different isoforms of TGF-β and the latent TGF-β binding protein (LTBP) by rat Kupffer cells. J. Hepatol. 29, 915-922 (1998).
42. X. Zhang, W.P. Yu, L. Gao, K.B. Wei, J.L. Ju and J.Z. Xu, Effects of lipopolysaccharides stimulated Kupffer cells on activation of rat hepatic stellate cells. World J. Gastroenterol. 10, 610-613 (2004).
43. J.S. Duffield, The inflammatory macrophage: a story of Jekyll and Hyde. Clin. Sci. (London) 104, 27-38 (2003).
44. M. Granado, A.I. Martin, T. Priego, M.A. Villanua and A. Lopez-Calderon, Inactivation of Kupffer cells by gadolinium administration prevents lipopolysaccharide-induced decrease in liver insulin-like growth factor-I and IGF-binding protein-3 gene expression. J. Endocrinol. 188, 503-511 (2006).
45. E. Seki, H. Tsutsui, Y. Iimuro, T. Naka, G. Son, S. Akira, T. Kishimoto, K. Nakanishi and J. Fujimoto, Contribution of Toll-like receptor/myeloid differentiation factor 88 signaling to murine liver regeneration. Hepatology 41, 443-450 (2005).
46. Y. Yamada, I. Kirillova, J.J. Peschon and N. Fausto, Initiation of liver growth by tumor necrosis factor: deficient liver regeneration in mice lacking type I tumor necrosis factor receptor. Proc. Natl. Acad. Sci. USA 94, 1441-1446 (1997).
47. D.E. Cressman, L.E. Greenbaum, R.A. DeAngelis, G. Ciliberto, E.E. Furth,V. Poli and R. Taub, Liver failure and defective hepatocyte regeneration in interleukin-6-deficient mice. Science 274, 1379-1383 (1996).
48. N. Selzner, M. Selzner, B. Odermatt, Y. Tian, N. Van Rooijen and P.A. Clavien, ICAM-1 triggers liver regeneration through leukocyte recruitment and Kupffer cell-dependent release of TNF-alpha/IL-6 in mice. Gastroenterology 124, 692-700 (2003).
49. K. Enomoto, Y. Nishikawa, Y. Omori, T. Tokairin, M. Yoshida, N. Ohi, T. Nishimura, Y. Yamamoto and Q. Li, Cell biology and pathology of liver sinusoidal endothelial cells. Med. Electron Microsc. 37, 208-215 (2004).
50. M. van Oosten, E.S. van Amersfoort, T.J. van Berkel and J. Kuiper, Scavenger receptor-like receptors for the binding of lipopolysaccharide and lipoteichoic acid to liver endothelial and Kupffer cells. J. Endotoxin. Res. 7, 381-384 (2001).
51. D.P. Praaning-van Dalen, A.M. De Leeuw, A. Brower and D.L. Knook, Rat liver endothelial cells have a greater capacity than Kupffer cells to endocytose N-acetylglucosamine- and mannose-terminated glycoproteins. Hepatology 7, 672-679 (1987).
52. I. Kosugi, H. Muro, H. Shirasawa and I. Ito, Endocytosis of soluble IgG immune complex and its transport to lysosomes in hepatic sinusoidal endothelial cells. J. Hepatol. 16, 106-114 (1992).
53. L. Dini, A. Lentini, G.D. Diez, M. Rocha, L. Falasca, L. Serafino and F. Vidal-Vanaclocha, Phagocytosis of apoptotic bodies by liver endothelial cells. J. Cell Sci. 108, 967-973 (1995).
54. B. Smedsrod, H. Pertoft, S. Gustanfson and T.C. Laurent, Scavenger functions of the liver endothelial cell. Biochem. J. 266, 313-327 (1990).
55. B. Zhou, J.A. Oka, A. Singh and P.H. Weigel, Purification and subunit characterization of the rat liver endocytic hyaluronan receptor. J. Biol. Chem. 274, 33831-33834 (1999).
56. T. Yoshioka, K. Yamamoto, H. Kobashi, M. Tomita and T. Tsuji, Receptor-mediated endocytosis of chemically modified albumins by sinusoidal endothelial cells and Kupffer cells in rat and human liver. Liver 14, 129-137 (1994).
57. I. Oynebraten, B. Hansen, B. Smedsrod and L. Uhlin-Hansen, Serglycin secreted by leukocytes is efficiently eliminated from the circulation by sinusoidal scavenger endothelial cells in the liver. J. Leukoc. Biol. 67, 183-188 (2000).
58. S. Esbach, M.F. Stins, A. Brouwer, P.J. Roholl, T.J. van Berkel and D.L. Knook, Morphological characterization of scavenger receptor-mediated processing of modified lipoproteins by rat liver endothelial cells. Exp. Cell Res. 210, 62-70 (1994).
59. M.J. Duryee, T.L. Freeman, M.S. Willis, C.D. Hunter, B.C. Hamilton Iii, H. Suzuki, D.J. Tuma, L.W. Klassen and G.M. Thiele, Scavenger receptors on sinusoidal liver endothelial cells (SECs) are involved in the uptake of aldehyde-modified proteins. Mol. Pharmacol. 68, 1423-1430 (2005).
60. B. Hansen, P. Longati, K. Elvevold, G.I. Nedredal, K. Schledzewski, R. Olsen, M. Falkowski, J. Kzhyshkowska, F. Carlsson, S. Johansson, B. Smedsrod, S. Goerdt and P. McCourt, Stabilin-1 and stabilin-2 are both directed into the early endocytic pathway in hepatic sinusoidal endothelium via interactions with clathrin/AP-2, independent of ligand binding. Exp. Cell Res. 303, 160-173 (2005).
61. K. Nakajou, S. Horiuchi, M. Sakai, K. Hirata, M. Tanaka, M. Takeya, T. Kai and M. Otagiri, CD36 is not involved in scavenger receptor-mediated endocytic uptake of glycolaldehyde- and methylglyoxal-modified proteins by liver endothelial cells. J. Biochem. (Tokyo) 137, 607-616 (2005).
62. W.M.J.M. Bogers, R.K. Stad, D.J. Janssen, F.A. Prins, N. Van Rooijen, L.A. Van Es and M.R. Daha, Kupffer cell depletion in vivo results in clearance of large-sized IgA aggregates in rats by liver endothelial cells. Clin. Exp. Immunol. 85, 128-136 (1991).
63. Y. Shiratori, H. Jin'nai, H. Teraoka, S. Matano, K. Matsumoto, K. Kamii, M. Tanaka and K. Okano, Phagocytic properties of hepatic endothelial cells and splenic macrophages compensating for a decreased phagocytic function of Kupffer cells in the chronically ethanol-fed rats. Exp. Cell Biol. 57, 300-309 (1989).
64. A.-M. Steffan, J.-L. Gendrault, R.S. McCuskey, P.A. McCuskey and A. Kirn, Phagocytosis, an unrecognized property of murine endothelial liver cells. Hepatology 6, 830-836 (1986).
65. N. Hashimoto, T. Watanabe, Y. Shiratori, Y. Ikeda, H. Kato, K. Han, H. Yamada, G. Toda and K. Kurokawa, Prostanoid secretion by rat hepatic sinusoidal endothelial cells and its regulation by exogenous adenosine triphosphate. Hepatology 21, 1713-1718 (1995).
66. A.T. Eakes and M.S. Olson, Regulation of endothelin synthesis in hepatic endothelial cells. Am. J. Physiol. 274, G1068-G1076 (1998).
67. S. Misquith, S. Wattiaux-De Coninck and R. Wattiaux, Intracellular degradation by liver endothelial cells. Molec. Cell. Biochem. 91, 63-74 (1989).
68. Z. Spolarics, Endotoxin stimulates gene expression of ROS-eliminating pathways in rat hepatic endothelial and Kupffer cells. Am. J. Physiol. 270, G660-G666 (1996).
69. Y. Mizoguchi, Y. Ichikawa, K. Kioka, N. Kawada, K. Kobayashi and S. Yamamoto, Effects of arachidonic acid metabolites and interleukin-1 on platelet activating factor production by hepatic sinusoidal endothelial cells from mice. J. Gastroenterol. Hepatol. 6, 283-288 (1991).
70. S. Arii and M. Imamura, Physiological role of sinusoidal endothelial cells and Kupffer cells and their implications in the pathogenesis of liver injury. J. Hepatobiliary Pancreat. Surg. 7, 40-48 (2000).
71. H. Ohira, K. Abe, J. Yokokawa, J. Takiguchi, T. Rai, S. Shishido and Y. Sato, Adhesion molecules and CXC chemokines in endotoxin-induced liver injury. Fukushima J. Med. Sci. 49, 1-13 (2003).
72. J.Y. Scoazec and G. Feldmann, The cell adhesion molecules of hepatic sinusoidal endothelial cells. J. Hepatol. 20, 296-300 (1994).
73. Y. Komatsu, Y. Shiratori, T. Kawase, N. Hashimoto, K.K. Han, S. Shiina and M. Matsumura. Role of polymorphonuclear leukocytes in galactosamine hepatitis: mechanism of adherence to hepatic endothelial cells. Hepatology 20, 1548-1556 (1994).
74. P.A. Knolle and G. Gerken, Local control of the immune response in the liver. Immunol. Rev. 174, 21-34 (2000).
75. P.A. Knolle and A. Limmer, Control of immune responses by savenger liver endothelial cells. Swiss Med. Weekly 133, 501-506 (2003).
76. H.F. Hendriks,W.A.Verhoofstad, A. Brouwer, A.M. De Leeuw and D.L. Knook, Perisinusoidal fat-storing cells are the main vitamin A storage cells in rat liver. Exp. Cell Res. 160, 138-149 (1985).
77. R. Blomhoff and K. Wake, Perisinusoidal stellate cells of the liver: Important roles in retinol metabolism and fibrosis. FASEB J. 5, 271-277 (1991).
78. M.J. Arthur, A. Stanley, J.P. Iredale, J.A. Rafferty, R.M. Hembry and S.L. Friedman, Secretion of 72 kDa type IV collagnease/gelatinase by cultured human lipocytes. Analysis of gene expression, protein synthesis and proteinase activity. Biochem. J. 287, 701-707 (1992).
79. S.L. Friedman, Cellular sources of collagen and regulation of collagen production in liver. Semin. Liver Dis. 10, 20-29 (1990).
80. S.L. Friedman, F.J. Roll, J.K. Boyles and D.M. Bissell, Hepatic lipocytes: the principle collagen-producing cells of normal rat liver. Proc. Natl. Acad. Sci. USA 82, 8681-8685 (1985).
81. I. Ogata, S. Mochida, T. Tomiya and W. Fujiwara, Minor contribution of hepatocytes to collagen production in normal and early fibrotic rat livers. Hepatology 14, 361-367 (1991).
82. Y. Shiratori, T. Ichida, A. Geerts and E.Wisse, Modulation of collagen synthesis by fat-storing cells, isolated from CCl4- or vitamin A- treated rats. Dig. Dis. Sci. 32, 1281-1289 (1987).
83. K.Y. Kim, I. Choi and S.S. Kim, Progression of hepatic stellate cell activation is associated with the level of oxidative stress rather than cytokines during CCl4-induced fibrogenesis. Mol. Cells 10, 289-300 (2000).
84. A.M. Gressner, Transdifferentiation of hepatic stellate cells (Ito cells) to myofibroblasts: a key event in hepatic fibrogenesis. Kidney Int. Suppl. 54, S39-S45 (1996).
85. S.W. French, H. Takahashi, K. Wong and C.L. Mendenhall, Ito cell activation induced by chronic ethanol feeding in the presence of different dietary fats. Alcohol Alcohol Suppl. 1, 357-361 (1991).
86. S.L. Friedman, Molecular mechanisms of hepatic fibrosis and principles of therapy. J. Gastroenterol. 32, 424-430 (1997).
87. K. Ikeda, T. Wakahara, Y.Q. Wang, H. Kadoya, N. Kawada and K. Kaneda, In vitro migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation. Hepatology 29, 1760-1767 (1999).
88. T. Knittel, M. Mehde, D. Kobold, B. Saile, C. Dinter and G. Ramadori, Expression patterns of matrix metalloproteinases and their inhibitors in parenchymal and non-parenchymal cells of rat liver: regulation by TNF-α and TGF-β1. J. Hepatol. 30, 48-60 (1999).
89. C. Hellerbrand, S.C. Wang, H. Tsukamoto, D.A. Brenner and R.A. Rippe, Expression of intracellular adhesion molecule 1 by activated hepatic stellate cells. Hepatology 24, 670-676 (1996).
90. C.R. Gandhi,T. Uemura and R.H.Kuddus, Endotoxin causes up-regulation of endothelin receptors in cultured hepatic stellate cells via nitric oxide-dependent and -independent mechanisms. Br. J. Pharmacol. 131, 319-327 (2000).
91. M.A. Freudenberg, D.Keppler and C. Galanos, Requirement for lipopolysaccharide-responsive macrophages in galactosamine-induced sensitization to endotoxin. Infect. Immun. 51, 891-895 (1986).
92. H.L. Schieferdecker, G. Schlaf, M. Koleva, O. Gotze and K. Jungermann, Induction of functional anaphylatoxin C5a receptors on hepatocytes by in vivo treatment of rats with IL-6. J. Immunol. 164, 5453-5458 (2000).
93. H. Tsukamoto, Cytokine regulation of hepatic stellate cells in liver fibrosis. Alcohol Clin. Exp. Res. 23, 911-916 (1999).
94. L. Wong, G. Yamasaki, R.J. Johnson and S.L. Friedman, Induction of beta-platelet-derived growth factor receptor in rat hepatic lipocytes during cellular activation in vivo and in culture. J. Clin. Invest. 94, 1563-1569 (1994).
95. Y. Xu, M. Rojkind and M.J. Czaja, Regulation of monocyte chemoattractant protein 1 by cytokines and oxygen free radicals in rat hepatic fat-storing cells. Gastroenterology 110, 1870-1877 (1996).
96. T. Knittel, T. Janneck, L. Muller, P. Fellmer and G. Ramadori, Transforming growth factor beta 1-regulated gene expression of Ito cells. Hepatology 24, 352-360 (1996).
97. L. Helyar, D.S. Bundschuh, J.D. Laskin and D.L. Laskin, Hepatic fat storing cells produce nitric oxide and hydrogen peroxide in response to bacterially-derived lipopolysaccharide, in Cells of the Hepatic Sinusoid, Vol. 4, D.L. Knook and K. Decker (Eds), Kupffer Cell Foundation, Amsterdam, The Netherlands, 1993, pp. 394-396.
98. L. Helyar, D.S. Bundschuh, J.D. Laskin and D.L. Laskin, Induction of hepatic Ito cell nitric oxide production by acute endotoxemia. Hepatology 12, 1509-1515 (1994).
99. A. Athari, K. Hanecke and K. Jungermann, Prostaglandin F2 alpha andD2 release from primary Ito cell cultures after stimulation with noradrenaline and ATP but not adenosine. Hepatology 20, 142-148 (1994).
100. B.H. Davis, R.T. Kramer and N.O. Davidson, Retinoic acid modulates rat Ito cell proliferation, collagen, and transforming growth factor beta production. J. Clin. Invest. 86, 2062-2070 (1990).
101. G. Poli, Pathogenesis of liver fibrosis: role of oxidative stress. Mol. Aspects Med. 21, 49-98 (2000).
102. G. Ramadori, T. Knittel, M. Odenthal, S. Schwogler, K. Neubauer and K. Meyer zum Buschenfelde, Synthesis of cellular fibronectin by rat liver fat-storing (Ito) cells: regulation by cytokines. Gastroenterology 103, 1313-1321 (1992).
103. R.S. Britton and B.R. Bacon, Intracellular signaling pathways in stellate cell activation. Alcohol Clin. Exp. Res. 23, 922-925 (1999).
104. S.L. Friedman, Stellate cell activation in alcoholic fibrosis-an overview. Alcohol Clin. Exp. Res. 23, 904-910 (1999).
105. H.L. Reeves and S.L. Friedman, Activation of hepatic stellate cells-a key issue in liver fibrosis. Front. Biosci. 7, d808-d826 (2002).
106. H. Higuchi and G.J. Gores, Mechanisms of liver injury: an overview. Curr. Mol. Med. 3, 483-490 (2003).
107. S.S. Zhan, J.X. Jiang, J.Wu,C. Halsted, S.L. Friedman, M.A. Zern and N.J.Torok, Phagocytosis of apoptotic bodies by hepatic stellate cells induces NADPH oxidase and is associated with liver fibrosis in vivo. Hepatology 43, 435-443 (2006).
108. C.C. Prosser, R.D. Yen and J.Wu, Molecular therapy for hepatic injury and fibrosis: where are we? World J. Gastroenterol. 12, 509-515 (2006).
109. H. Sprenger, A. Kaufmann, H. Garn, B. Lahme, D. Gemsa and A.M. Gressner, Differential expression of monocyte chemotactic protein-1 (MCP-1) in transforming rat hepatic stellate cells. J. Hepatol. 30, 88-94 (1999).
110. R.H. Wiltrout, Regulation and antimetastatic functions of liver-associated natural killer cells. Immunol. Rev. 174, 63-76 (2000).
111. M.A. Morris and K. Ley, Trafficking of natural killer cells. Curr. Mol. Med. 4, 431-438 (2004).
112. M. Kronenberg and L. Gapin, The unconventional lifestyle of NKT cells. Nat. Rev. Immunol. 2, 557-568 (2002).
113. M. Emoto, M. Miyamoto, I. Yoshizawa, Y. Emoto, U.E. Schaible, E. Kita and S.H. Kaufmann, Critical role of NK cells rather than V alpha 14(+)NKT cells in lipopolysaccharide-induced lethal shock in mice. J. Immunol. 169, 1426-1432 (2002).
114. Z.X. Liu, S. Govindarajan and N. Kaplowitz, Innate immune system plays a critical role in determining the progression and severity of acetaminophen hepatotoxicity. Gastroenterology 127, 1760-1774 (2004).
115. K. Takeda, Y. Hayakawa, L. Van Kaer, H. Matsuda, H. Yagita and K. Okumura, Critical contribution of liver natural killer T cells to a murine model of hepatitis. Proc. Natl. Acad. Sci. USA 97, 5498-5503 (2000).
116. B.H. Rumack, Acetaminophen misconceptions. Hepatology 40, 10-15 (2004).
117. V.J. Navarro and J.R. Senior, Drug-related hepatotoxicity. N. Engl. J. Med. 354, 731-739 (2006).
118. M.J. Zamek-Gliszczynski, K.A. Hoffmaster,X. Tian, R. Zhao, J.W. Polli, J.E. Humphreys, L.O. Webster, A.S. Bridges, J.C. Kalvass and K.L. Brouwer, Multiple mechanisms are involved in the biliary excretion of acetaminophen sulfate in the rat: role of Mrp2 and Bcrp1. Drug Metab. Dispos. 33, 1158-1165 (2005).
119. H. Xiong, K.C. Turner, E.S. Ward, P.L. Jansen and K.L. Brouwer, Altered hepatobiliary disposition of acetaminophen glucuronide in isolated perfused livers from multidrug resistanceassociated protein 2-deficient TR(-) rats. J. Pharmacol. Exp. Ther. 295, 512-518 (2000).
120. S.S. Lee, J.T. Buters, T. Pineau, P. Fernandez-Salguero and F.J. Gonzalez, Role of CYP2E1 in the hepatotoxicity of acetaminophen. J. Biol. Chem. 271, 12063-12067 (1996).
121. D.C. Dahlin, G.T. Miwa, A.Y. Lu and S.D. Nelson, N-acetyl-p-benzoquinone imine: a cytochrome P-450-mediated oxidation product of acetaminophen. Proc. Natl. Acad. Sci. USA 81, 1327-1331 (1984).
122. C. Chen, G.E. Hennig and J.E. Manautou, Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats. Drug Metab. Dispos. 31, 798-804 (2003).
123. J.R. Mitchell, D.J. Jollow,W.Z. Potter, J.R. Gillette and B.B. Brodie, Acetaminophen-induced hepatic necrosis. IV. Protective role of glutathione. J. Pharmacol. Exp. Ther. 187, 211-217 (1973).
124. D.J. Jollow, J.R. Mitchell, W.Z. Potter, D.C. Davis, J.R. Gillette and B.B. Brodie, Acetaminophen-induced hepatic necrosis. II. Role of covalent binding in vivo. J. Pharmacol. Exp. Ther. 187, 195-202 (1973).
125. K.J. Hoffmann, A.J. Streeter, D.B. Axworthy and T.A. Baillie, Identification of the major covalent adduct formed in vitro and in vivo between acetaminophen and mouse liver proteins. Mol. Pharmacol. 27, 566-573 (1985).
126. A.J. Streeter, D.C. Dahlin, S.D. Nelson and T.A. Baillie, The covalent binding of acetaminophen to protein. Evidence for cysteine residues as major sites of arylation in vitro. Chem. Biol. Interact. 48, 349-366 (1984).
127. W. Chen, J.P. Shockcor, R. Tonge, A. Hunter, C. Gartner and S.D. Nelson, Protein and nonprotein cysteinyl thiol modification by N-acetyl-p-benzoquinone imine via a novel ipso adduct. Biochemistry 38, 8159-8166 (1999).
128. S.D. Cohen, N.R. Pumford, E.A. Khairallah, K. Boekelheide, L.R. Pohl, H.R. Amouzadeh and J.A. Hinson, Selective protein covalent binding and target organ toxicity. Toxicol. Appl. Pharmacol. 143, 1-12 (1997).
129. P.C. Burcham and A.W. Harman, Acetaminophen toxicity results in site-specific mitochondrial damage in isolated mouse hepatocytes. J. Biol. Chem. 266, 5049-5054 (1991).
130. L.L. Meyers, W.P. Beierschmitt, E.A. Khairallah and S.D. Cohen, Acetaminophen-induced inhibition of hepatic mitochondrial respiration in mice. Toxicol. Appl. Pharmacol. 93, 378-387 (1988).
131. H. Jaeschke, Glutathione disulfide formation and oxidant stress during acetaminophen-induced hepatotoxicity in mice in vivo: the protective effect of allopurinol. J. Pharmacol. Exp. Ther. 255, 935-941 (1990).
132. R.R. Ramsay, M.S. Rashed and S.D. Nelson, In vitro effects of acetaminophen metabolites and analogs on the respiration of mouse liver mitochondria. Arch. Biochem. Biophys. 273, 449-457 (1989).
133. M.A. Tirmenstein and S.D. Nelson, Acetaminophen-induced oxidation of protein thiols. Contribution of impaired thiol-metabolizing enzymes and the breakdown of adenine nucleotides. J. Biol. Chem. 265, 3059-3065 (1990).
134. N.R. Pumford and N.C. Halmes, Protein targets of xenobiotic reactive intermediates. Annu. Rev. Pharmacol. Toxicol. 37, 91-117 (1997).
135. S. Lores Arnaiz, S. Llesuy, J.C. Cutrin and A. Boveris, Oxidative stress by acute acetaminophen administration in mouse liver. Free Radic. Biol. Med. 19, 303-310 (1995).
136. L. Prescott, Paracetamol (Acetaminophen): A Critical Bibliographic Review. Taylor&Francis, London, UK, 1996.
137. D.L. Laskin, C.R. Gardner, V.F. Price and D.J. Jollow, Modulation of macrophage functioning abrogates the acute hepatotoxicity of acetaminophen. Hepatology 21, 1045-1050 (1995).
138. V.F. Price, J.M. Schulte, S.M. Spaethe and D.J. Jollow, Mechanism of fasting-induced suppression of acetaminophen glucuronidation in the rat. Adv. Exp. Med. Biol. 197, 697-706 (1986).
139. D.L. Laskin, A.M. Pilaro and S. Ji, Potential role of macrophages in acetaminophen hepatotoxicity. II. Mechanisms of macrophage accumulation and activation. Toxicol. Appl. Pharmacol. 86, 216-226 (1986).
140. C.R. Gardner, D.E. Heck, C.S. Yang, P.E. Thomas, X.-J. Zhang, G.L. DeGeorge, J.D. Laskin and D.L. Laskin, Role of nitric oxide in acetaminophen-induced hepatotoxicity in the rat. Hepatology 27, 748-754 (1998).
141. C.R. Gardner, J.D. Laskin, D.M. Dambach, M. Sacco, S.K. Durham, M.K. Bruno, S.D. Cohen, M.K. Gordon, D.R. Gerecke, P. Zhou and D.L. Laskin, Reduced hepatotoxicity of acetaminophen in mice lacking inducible nitric oxide synthase: potential role of tumor necrosis factor-α and interleukin-10. Toxicol. Appl. Pharmacol. 184, 27-36 (2002).
142. C.R. Gardner, J.D. Laskin, D.M. Dambach, H. Chiu, S.K. Durham, P. Zhou, M. Bruno, D.R. Gerecke, M.K. Gordon and D.L. Laskin, Exaggerated hepatotoxicity of acetaminophen in mice lacking tumor necrosis factor receptor-1. Potential role of inflammatory mediators. Toxicol. Appl. Pharmacol. 192, 119-130 (2003).
143. D.M. Dambach, S.K. Durham, J.D. Laskin and D.L. Laskin, Distinct roles of NF-κB p50 in the regulation of acetaminophen-induced inflammatory mediator production and hepatotoxicity. Toxicol. Appl. Pharmacol. 211, 157-165 (2006).
144. D.M. Dambach, L.M. Watson, K.R. Gray, S.K. Durham and D.L. Laskin, Role of CCR2 in macrophage migration into the liver during acetaminophen-induced hepatotoxicity in the mouse. Hepatology 35, 1093-1103 (2002).
145. Y. Ishida, T. Kondo, T. Ohshima, H. Fujiwara, Y. Iwakura and N. Mukaida, A pivotal involvement of IFN-γ in the pathogenesis of acetaminophen-induced acute liver injury. FASEB J. 16, 1227-1236 (2002).
146. R.D. Goldin, I.D. Ratnayaka, C.S. Breach, I.N. Brown and S.N. Wickramasinghe, Role of macrophages in acetaminophen (paracetamol)-induced hepatotoxicity. J. Pathol. 179, 432-435 (1996).
147. S.L. Michael, N.R. Pumford, P.R. Mayeux, M.R. Niesman and J.A. Hinson, Pretreatment of mice with macrophage inactivators decreases acetaminophen hepatotoxicity and the formation of reactive oxygen and nitrogen species. Hepatology 30, 186-195 (1999).
148. A. Neyrinck, S.L. Eeckhoudt, C.J. Meunier, S. Pampfer, H.S. Taper, R.K. Verbeeck and N. Delzenne, Modulation of paracetamol metabolism by Kupffer cells: a study on rat liver slices. Life Sci. 65, 2851-2859 (1999).
149. Y. Kamanaka, A. Kawabata, H. Matsuya, C. Taga, F. Sekiguchi and N. Kawao, Effect of a potent iNOS inhibitor (ONO-1714) on acetaminophen-induced hepatotoxicity in the rat. Life Sci. 74, 793-802 (2003).
150. Y. Ito, E.R. Abril, N.W. Bethea and R.S. McCuskey, Role of nitric oxide in hepatic microvascular injury elicited by acetaminophen in mice. Am. J. Physiol. Gastrointest. Liver Physiol. 286, G60-G67 (2004).
151. O. Mirochnitchenko, M. Weisbrot-Lefkowitz, K. Reuhl, L. Chen, C. Yang and M. Inouye, Acetaminophen toxicity. Opposite effects of two forms of glutathione peroxidase. J. Biol. Chem. 274, 10349-10355 (1999).
152. H.Z. Toklu, A.O. Sehirli, A.Velioglu-Ogunc, S. Cetinel and G. Sener, Acetaminophen-induced toxicity is prevented by beta-d-glucan treatment in mice. Eur. J. Pharmacol. 543, 133-140 (2006).
153. G. Sener, H.Z. Toklu, A.O. Sehirli, A. Velioglu-Ogunc, S. Cetinel and N. Gedik, Protective effects of resveratrol against acetaminophen-induced toxicity in mice. Hepatol. Res. 35, 62-68 (2006).
154. G.E. Ronsein, D.B. Guidi, J.C. Benassi, D.W. Filho, R.C. Pedrosa and R.C. Pedrosa, Cytoprotective effects of carvedilol against oxygen free radical generation in rat liver. Redox. Rep. 10, 131-137 (2005).
155. H.S. Oz, C.J. McClain, H.T. Nagasawa, M.B. Ray, W.J. de Villiers and T.S. Chen, Diverse antioxidants protect against acetaminophen hepatotoxicity. J. Biochem. Mol. Toxicol. 18, 361-368 (2004).
156. R.F. Speck, C. Schranz and B.H. Lauterburg, Prednisolone stimulates hepatic glutathione synthesis in mice. Protection by prednisolone against acetaminophen hepatotoxicity in vivo. J. Hepatol. 18, 62-67 (1993).
157. C. Madhu, T. Maziasz and C.D. Klaassen, Effect of pregnenolone-16 alpha-carbonitrile and dexamethasone on acetaminophen-induced hepatotoxicity in mice. Toxicol. Appl. Pharmacol. 115, 191-198 (1992).
158. G.L. Monto, P.J. Scheuer, R.L. Hansing and A.K. Burroughs, Attenuation of acetaminophen hepatitis by prostaglandin E2. A histopathological study. Dig. Dis. Sci. 39, 957-960 (1994).
159. S.P. Lim, F.J. Andrews and P.E. O'Brien, Misoprostol protection against acetaminopheninduced hepatotoxicity in the rat. Dig. Dis. Sci. 39, 1249-1256 (1994).
160. S.P. Lim, F.J. Andrews and P.E. O'Brien, Acetaminophen-induced microvascular injury in the rat liver: protection with misoprostol. Hepatology 22, 1776-1781 (1995).
161. P.J. Murray, Understanding and exploiting the endogenous interleukin-10/STAT3-mediated anti-inflammatory response. Curr. Opin. Pharmacol. 6, 379-386 (2006).
162. C. Ju, T.P. Reilly, M. Bourdi, M.F. Radonovich, J.N. Brady, J.W. George and L.R. Pohl, Protective role of Kupffer cells in acetaminophen-induced hepatic injury in mice. Chem. Res. Toxicol. 15, 1504-1513 (2002).
163. C. Cover, J. Liu, A. Farhood, E. Malle, M.P.Waalkes, M.L. Bajt and H. Jaeschke, Pathophysiological role of the acute inflammatory response during acetaminophen hepatotoxicity. Toxicol. Appl. Pharmacol. 216, 98-107 (2006).
164. M. Bourdi, Y. Masubuchi, T.P. Reilly, H.R. Amouzadeh, J.L. Martin, J.W. George, A.G. Shah and L.R. Pohl, Protection against acetaminophen-induced liver injury and lethality by interleukin 10: role of inducible nitric oxide synthase. Hepatology 35, 289-298 (2002).
165. C.M. Hogaboam, C.L. Bone-Larson, M.L. Steinhauser, A. Matsukawa, J. Gosling, L. Boring, I.F. Charo, K.J. Simpson, N.W. Lukacs and S.L. Kunkel, Exaggerated hepatic injury due to acetaminophen challenge in mice lacking C-C chemokine receptor 2. Am. J. Pathol. 156, 1245-1252 (2000).
166. R.F. Schwabe and D.A. Brenner, Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role of IKK, JNK, and ROS pathways. Am. J. Physiol. Gastrointest. Liver Physiol. 290, G583-G589 (2006).
167. H.Wajant, K. Pfizenmaier and P. Scheurich, Tumor necrosis factor signaling. Cell Death Differ. 10, 45-65 (2003).
168. M. Satoh and M. Yamazaki, Tumor necrosis factor stimulates DNA synthesis of mouse hepatocytes in primary culture and is suppressed by transforming growth factor beta and interleukin 6. J. Cell Physiol. 150, 134-139 (1992).
169. H.S. Beyer and A. Theologides, Tumor necrosis factor-alpha is a direct hepatocyte mitogen in the rat. Biochem. Mol. Biol. Int. 29, 1-4 (1993).
170. H. Chiu, C.R. Gardner, D.M. Dambach, J.A. Brittingham, S.K. Durham, J.D. Laskin and D.L. Laskin, Role of p55 tumor necrosis factor receptor 1 in acetaminophen-induced antioxidant defense. Am. J. Physiol. Gastrointest. Liver Physiol. 285, G959-G966 (2003).
171. H. Chiu, C.R. Gardner, D.M. Dambach, S.K. Durham, J.A. Brittingham, J.D. Laskin and D.L. Laskin, Role of tumor necrosis factor receptor 1 (p55) in hepatocyte proliferation during acetaminophen-induced toxicity in mice. Toxicol. Appl. Pharmacol. 193, 218-227 (2003).
172. L.P. James, L.W. Lamps, S. McCullough and J.A. Hinson, Interleukin 6 and hepatocyte regeneration in acetaminophen toxicity in the mouse. Biochem. Biophys. Res. Commun. 309, 857-863 (2003).
173. M.E. Blazka, D.R. Germolec, P. Simeonova, A. Bruccoleri, K.R. Pennypacker and M.I. Luster, Acetaminophen-induced hepatotoxicity is associated with early changes in NF-κB and NF-IL6 DNA binding activity. J. Inflamm. 47, 138-150 (1995).
174. I. Bauer, B. Vollmar, H. Jaeschke, H. Rensing, T. Kraemer, R. Larsen and M. Bauer, Transcriptional activation of heme oxygenase-1 and its functional significance in acetaminophen-induced hepatitis and hepatocellular injury in the rat. J. Hepatol. 33, 395-406 (2000).
175. P. Celec, Nuclear factor kappa B-molecular biomedicine: the next generation. Biomed. Pharmacother. 58, 365-371 (2004).
176. M.L. Chaisson, J.T. Brooling,W. Ladiges, S. Tsai and N. Fausto, Hepatocyte-specific inhibition of NF-kappaB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J. Clin. Invest. 110, 193-202 (2002).
177. M.E. Blazka, A. Bruccoleri, P. Simeonova, D.R. Germolec, K.R. Pennypacker and M.I. Luster, Acetaminophen-induced hepatotoxicity is associated with early changes in AP-1 DNA binding activity. Res. Commun. Mol. Pathol. Pharmacol. 92, 259-273 (1996).
178. A. Gashler and V.P. Sukhatme, Early growth response protein 1 (Egr-1): prototype of a zincfinger family of transcription factors. Prog. Nucleic Acid Res. Mol. Biol. 50, 191-224 (1995).
179. H. Tsutsui, N. Kayagaki, K. Kuida, H. Nakano, N. Hayashi, K. Takeda, K. Matsui, S. Kashiwamura, T. Hada, S. Akira, H. Yagita, H. Okamura and K. Nakanishi, Caspase-1- independent, Fas/Fas ligand-mediated IL-18 secretion from macrophages causes acute liver injury in mice. Immunity 11, 359-367 (1999).
180. W.C. Liles, P.A. Kiener, J.A. Ledbetter, A. Aruffo and S.J. Klebanoff, Differential expression of Fas (CD95) and Fas ligand on normal human phagocytes: implications for the regulation of apoptosis in neutrophils. J. Exp. Med. 184, 429-440 (1996).
181. A.M. Hohlbaum, M.S. Gregory, S.T. Ju and A. Marshak-Rothstein, Fas ligand engagement of resident peritoneal macrophages in vivo induces apoptosis and the production of neutrophil chemotactic factors. J. Immunol. 167, 6217-6224 (2001).
182. R. Imamura, K. Konaka, N. Matsumoto, M. Hasegawa, M. Fukui, N. Mukaida, T. Kinoshita and T. Suda, Fas ligand induces cell-autonomous NF-kappaB activation and interleukin-8 production by a mechanism distinct from that of tumor necrosis factor-alpha. J. Biol. Chem. 279, 46415-46423 (2004).
183. S. Faouzi, B.E. Burckhardt, J.C. Hanson, C.B. Campe, L.W. Schrum, R.A. Rippe and J.J. Maher, Anti-Fas induces hepatic chemokines and promotes inflammation by an NF-kappa B-independent, caspase-3-dependent pathway. J. Biol. Chem. 276, 49077-49082 (2001).
184. R.M.Walker,W.J. Racz and T.F. McElligott, Acetaminophen-induced hepatotoxic congestion in mice. Hepatology 5, 233-240 (1985).
185. R.M. Walker, W.J. Racz and T.F. McElligott, Scanning electron microscopic examination of acetaminophen-induced hepatotoxicity and congestion in mice. Am. J. Pathol. 113, 321-330 (1983).
186. Y. Ito, N.W. Bethea, E.R. Abril and R.S. McCuskey, Early hepatic microvascular injury in response to acetaminophen toxicity. Microcirculation 10, 391-400 (2003).
187. Y. Ito, E.R. Abril, N.W. Bethea and R.S. McCuskey, Inhibition of matrix metalloproteinases minimizes hepatic microvascular injury in response to acetaminophen in mice. Toxicol. Sci. 83, 190-196 (2005).
188. R.S. McCuskey, Sinusoidal endothelial cells as an early target for hepatic toxicants. Clin. Hemorheol. Microcirc. 34, 5-10 (2006).
189. L.D. DeLeve,X.Wang, N. Kaplowitz, H.M. Shulman, J.A. Bart and A. van der Hoek, Sinusoidal endothelial cells as a target for acetaminophen toxicity. Direct action versus requirement for hepatocyte activation in different mouse strains. Biochem. Pharmacol. 53, 1339-1345 (1997).
190. T.R. Knight, A. Kurtz, M.L. Bajt, J.A. Hinson and H. Jaeschke, Vascular and hepatocellular peroxynitrite formation during acetaminophen toxicity: role of mitochondrial oxidant stress. Toxicol. Sci. 62, 212-220 (2001).
191. S.D. Salhanick, D. Orlow, D.E. Holt, S. Pavlides, W. Reenstra and J.A. Buras, Endothelially derived nitric oxide affects the severity of early acetaminophen-induced hepatic injury in mice. Acad. Emerg. Med. 13, 479-485 (2006).
192. T.A. Drixler, M.J. Vogten, E.D. Ritchie, T.J. van Vroonhoven, M.F. Gebbink, E.E. Voest and I.H. Borel Rinkes, Liver regeneration is an angiogenesis-associated phenomenon. Ann. Surg. 236, 703-711; Discussion, 711-712 (2002).
193. B. Donahower, S.S. McCullough, R. Kurten, L.W. Lamps, P. Simpson, J.A. Hinson and L.P. James, Vascular endothelial growth factor and hepatocyte regeneration in acetaminophen toxicity. Am. J. Physiol. Gastrointest. Liver Physiol. 291, G102-G109 (2006).
194. J. LeCouter, D.R. Moritz, B. Li, G.L. Phillips, X.H. Liang, H.P. Gerber, K.J. Hillan and N. Ferrara, Angiogenesis-independent endothelial protection of liver: role of VEGFR-1. Science 299, 890-893 (2003).
195. A.J. Archambault, M.G. Sirois, P.N. Bernatchez, C. Fiset and P.S. Haddad, Vascular endothelial growth factor production by isolated rat hepatocytes after cold ischemia-warm reoxygenation. Liver Transpl. 7, 988-997 (2001).
196. H. Takahashi and M. Shibuya, The vascular endothelial growth factor (VEGF)/VEGF receptor system and its role under physiological and pathological conditions. Clin. Sci. (London) 109, 227-241 (2005).
197. V. Shah, F.G. Haddad, G. Garcia-Cardena, J.A. Frangos, A. Mennone, R.J. Groszmann and W.C. Sessa, Liver sinusoidal endothelial cells are responsible for nitric oxide modulation of resistance in the hepatic sinusoids. J. Clin. Invest. 100, 2923-2930 (1997).
198. A.J. Davidson and L.I. Zon, Biomedicine. Love, honor and protect (your liver). Science 299, 835-837 (2003).
199. K.D.Welch, T.P. Reilly,M. Bourdi, T. Hays, C.A. Pise-Masison, M.F. Radonovich, J.N. Brady, D.J. Dix and L.R. Pohl, Genomic identification of potential risk factors during acetaminopheninduced liver disease in susceptible and resistant strains of mice. Chem. Res. Toxicol. 19, 223-233 (2006).
200. H. Diao, S.Kon, K. Iwabuchi, C. Kimura, J. Morimoto, D. Ito,T. Segawa,M. Maeda, J. Hamuro, T. Nakayama, M. Taniguchi, H. Yagita, L. Van Kaer, K. Onoe, D. Denhardt, S. Rittling and T. Uede, Osteopontin as a mediator of NKT cell function in T cell-mediated liver diseases. Immunity 21, 539-550 (2004).
201. G.S. Smith, D.E. Nadig, E.R. Kokoska, H. Solomon, D.G. Tiniakos and T.A. Miller, Role of neutrophils in hepatotoxicity induced by oral acetaminophen administration in rats. J. Surg. Res. 80, 252-258 (1998).
202. J.A. Lawson, A. Farhood, R.D. Hopper, M.L. Bajt and H. Jaeschke, The hepatic inflammatory response after acetaminophen overdose: role of neutrophils. Toxicol. Sci. 54, 509-516 (2000).
203. J.R. Mitchell, D.J. Jollow, W.Z. Potter, D.C. Davis, J.R. Gillette and B.B. Brodie, Acetaminophen-induced hepatic necrosis. I. Role of drug metabolism. J. Pharmacol. Exp. Ther. 187, 185-194 (1973).
204. H.Wang, O. Bloom, M. Zhang, J.M.Vishnubhakat, M. Ombrellino, J. Che, A. Frazier,H.Yang, S. Ivanova, L. Borovikova, K.R. Manogue, E. Faist, E. Abraham, J. Andersson, U. Andersson, P.E. Molina, N.N. Abumrad, A. Sama and K.J. Tracey, HMG-1 as a late mediator of endotoxin lethality in mice. Science 285, 248-251 (1999).
205. P. Scaffidi, T. Misteli and M.E. Bianchi, Release of chromatin protein HMGB1 by necrotic cells triggers inflammation. Nature 418, 191-195 (2002).
206. J.W. Conlan and R.J. North, Neutrophils are essential for early anti-Listeria defense in the liver, but not in the spleen or peritoneal cavity, as revealed by a granulocyte-depleting monoclonal antibody. J. Exp. Med. 179, 259-268 (1994).
207. Y. Ishida, T. Kondo, A. Kimura, K. Tsuneyama, T. Takayasu and N. Mukaida, Opposite roles of neutrophils and macrophages in the pathogenesis of acetaminophen-induced acute liver injury. Eur. J. Immunol. 36, 1028-1038 (2006).
208. Z.X. Liu, D. Han, B. Gunawan and N. Kaplowitz, Neutrophil depletion protects against murine acetaminophen hepatotoxicity. Hepatology 43, 1220-1230 (2006).
209. L.W.Weber,M. Boll and A. Stampfl, Hepatotoxicity and mechanism of action of haloalkanes: carbon tetrachloride as a toxicological model. Crit. Rev. Toxicol. 33, 105-136 (2003).
210. S. Basu, Carbon tetrachloride-induced lipid peroxidation: eicosanoid formation and their regulation by antioxidant nutrients. Toxicology 189, 113-127 (2003).
211. A. Gruebele, K. Zawaski, D. Kaplan and R.F. Novak, Cytochrome P4502E1- and cytochrome P4502B1/2B2-catalyzed carbon tetrachloride metabolism: effects on signal transduction as demonstrated by altered immediate-early (c-Fos and c-Jun) gene expression and nuclear AP-1 and NF-kappa B transcription factor levels. Drug Metab. Dispos. 24, 15-22 (1996).
212. P.B. McCay, E.K. Lai, J.L. Poyer, C.M. DuBose and E.G. Janzen, Oxygen- and carbon-centered free radical formation during carbon tetrachloride metabolism. Observation of lipid radicals in vivo and in vitro. J. Biol. Chem. 259, 2135-2143 (1984).
213. J.L. Raucy, J.C. Kraner and J.M. Lasker, Bioactivation of halogenated hydrocarbons by cytochrome P4502E1. Crit. Rev. Toxicol. 23, 1-20 (1993).
214. F.W.Wong,W.Y. Chan and S.S. Lee, Resistance to carbon tetrachloride-induced hepatotoxicity in mice which lack CYP2E1 expression. Toxicol. Appl. Pharmacol. 153, 109-118 (1998).
215. B.A. Mico and L.R. Pohl, Reductive oxygenation of carbon tetrachloride: trichloromethylperoxyl radical as a possible intermediate in the conversion of carbon tetrachloride to electrophilic chlorine. Arch. Biochem. Biophys. 225, 596-609 (1983).
216. K.H. Cheeseman, E.F. Albano, A. Tomasi and T.F. Slater, Biochemical studies on the metabolic activation of halogenated alkanes. Environ. Health Perspect. 64, 85-101 (1985).
217. M. Comporti, Lipid peroxidation and cellular damage in toxic liver injury. Lab. Invest. 53, 599-623 (1985).
218. D.L. Tribble, T.Y.Awand D.P. Jones, The pathophysiological significance of lipid peroxidation in oxidative cell injury. Hepatology 7, 377-386 (1987).
219. R.E. Thiers, E.S. Reynolds and B.L. Vallee, The effect of carbon tetrachloride poisoning on subcellular metal distribution in rat liver. J. Biol. Chem. 235, 2130-2133 (1960).
220. E. Albano, R. Carini, M. Parola, G. Bellomo, L. Goria-Gatti, G. Poli and M.U. Dianzani, Effects of carbon tetrachloride on calcium homeostasis. A critical reconsideration. Biochem. Pharmacol. 38, 2719-2725 (1989).
221. O.G. Bjornsson, C.S. Bourgeois and G.F. Gibbons, Varying very low-density lipoprotein secretion of rat hepatocytes by altering cellular levels of calcium and the activity of protein kinase C. Eur. J. Clin. Invest. 28, 720-729 (1998).
222. D. Haouzi, M. Lekehal, A. Moreau, C. Moulis, G. Feldmann, M.A. Robin, P. Letteron, D. Fau and D. Pessayre, Cytochrome P450-generated reactive metabolites cause mitochondrial permeability transition, caspase activation and apoptosis in rat hepatocytes. Hepatology 32, 303-311 (2000).
223. P. Nicotera, G. Bellomo and S. Orrenius, Calcium-mediated mechanisms in chemically induced cell death. Annu. Rev. Pharmacol. Toxicol. 32, 449-470 (1992).
224. H. Jaeschke, C.W. Smith, M.G. Clemens, P.E. Ganey and R.A. Roth, Mechanisms of inflammatory liver injury: adhesion molecules and cytotoxicity of neutrophils. Toxicol. Appl. Pharmacol. 139, 213-226 (1996).
225. R. Timpl, Macromolecular organization of basement membranes. Curr. Opin. Cell Biol. 8, 618-624 (1996).
226. M. Gallai, I. Kovalszky, T. Knittel, K. Neubauer, T. Armbrust and G. Ramadori, Expression of extracellular matrix proteoglycans perlecan and decorin in carbon-tetrachloride-injured rat liver and in isolated liver cells. Am. J. Pathol. 148, 1463-1471 (1996).
227. I. Kovalszky, P. Nagy, B. Szende, K. Lapis, F. Szalay, A. Jeney and Z. Schaff, Experimental and human liver fibrogenesis. Scand. J. Gastroenterol. Suppl. 228, 51-55 (1998).
228. P.Y. Rescan, O. Loreal, J.R. Hassell, Y. Yamada, A. Guillouzo and B. Clement, Distribution and origin of the basement membrane component perlecan in rat liver and primary hepatocyte culture. Am. J. Pathol. 142, 199-208 (1993).
229. T. Roskams, J. Rosenbaum, R. De Vos, G. David and V. Desmet, Heparan sulfate proteoglycan expression in chronic cholestatic human liver diseases. Hepatology 24, 524-532 (1996).
230. E. Albanis and S.L. Friedman, Hepatic fibrosis. Pathogenesis and principles of therapy. Clin. Liver Dis. 5, 315-334, v-vi (2001).
231. M. Rojkind, M.A. Giambrone and L. Biempica, Collagen types in normal and cirrhotic liver. Gastroenterology 76, 710-719 (1979).
232. A.M. Gressner and M.G. Bachem, Cellular sources of noncollagenous matrix proteins: role of fat-storing cells in fibrogenesis. Semin. Liver Dis. 10, 30-46 (1990).
233. A.M. Gressner and M.G. Bachem, Molecular mechanisms of liver fibrogenesis-a homage to the role of activated fat-storing cells. Digestion 56, 335-346 (1995).
234. A. Geerts, P. Schellinck, L. Bouwens and E. Wisse, Cell population kinetics of Kupffer cells during the onset of fibrosis in rat liver by chronic carbon tetrachloride administration. J. Hepatol. 6, 50-56 (1988).
235. C. Orfila, J.C. Lepert, L. Alric, G. Carrera, M. Beraud, J.P. Vinel and B. Pipy, Expression of TNF-α and immunohistochemical distribution of hepatic macrophage surface markers in carbon tetrachloride-induced chronic liver injury in rats. Histochem. J. 31, 677-685 (1999).
236. D.K. Qiu, J. Hua, J.Q. Li and E.L. Li, CD14 expression on Kupffer cells during the course of carbon tetrachloride-mediated liver injury. Chin. J. Dig. Dis. 6, 137-141 (2005).
237. S.W. Luckey and D.R. Petersen, Activation of Kupffer cells during the course of carbon tetrachloride-induced liver injury and fibrosis in rats. Exp. Mol. Pathol. 71, 226-240 (2001).
238. C. Orfila, J.C. Lepert, L. Alric, G. Carrera, M. Beraud and B. Pipy, Immunohistochemical distribution of activated nuclear factor kappaB and peroxisome proliferator-activated receptors in carbon tetrachloride-induced chronic liver injury in rats. Histochem. Cell Biol. 123, 585-593 (2005).
239. K. Neubauer,A. Ritzel, B. Saile and G. Ramadori, Decrease of platelet-endothelial cell adhesion molecule 1-gene-expression in inflammatory cells and in endothelial cells in the rat liver following CCl4-administration and in vitro after treatment with TNF alpha. Immunol. Lett. 74, 153-164 (2000).
240. Y. Yang, S.A. Harvey and C.R. Gandhi, Kupffer cells are a major source of increased platelet activating factor in the CCl4-induced cirrhotic rat liver. J. Hepatol. 39, 200-207 (2003).
241. R. Kawashima, S. Mochida, A. Matsui, Z.Y. YouLuTu, K. Ishikawa, K. Toshima, F. Yamanobe, M. Inao, H. Ikeda, A. Ohno, S. Nagoshi, T. Uede and K. Fujiwara, Expression of osteopontin in Kupffer cells and hepatic macrophages and stellate cells in rat liver after carbon tetrachloride intoxication: a possible factor for macrophage migration into hepatic necrotic areas. Biochem. Biophys. Res. Commun. 256, 527-531 (1999).
242. R.J. Stenger, M. Petrelli, A. Segel, J.N.Williamson and E.A. Johnson, Modification of carbon tetrachloride hepatotoxicity by prior loading of the reticuloendothelial system with carbon particles. Am. J. Pathol. 57, 689-706 (1969).
243. M.J. Edwards, B.J. Keller, F.C. Kauffman and R.G. Thurman, The involvement of Kupffer cells in carbon tetrachloride toxicity. Toxicol. Appl. Pharmacol. 119, 275-279 (1993).
244. P. Muriel and Y. Escobar, Kupffer cells are responsible for liver cirrhosis induced by carbon tetrachloride. J. Appl. Toxicol. 23, 103-108 (2003).
245. C.A. Rivera, B.U. Bradford, K.J. Hunt, Y. Adachi, L.W. Schrum, D.R. Koop, E.R. Burchardt, R.A. Rippe and R.G. Thurman, Attenuation of CCl4-induced hepatic fibrosis by GdCl3 treatment or dietary glycine. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G200-G207 (2001).
246. L.A. Morio, H. Chiu, K.A. Sprowles, P. Zhou, D.E. Heck, M.K. Gordon and D.L. Laskin, Distinct roles of tumor necrosis factor-alpha and nitric oxide in acute liver injury induced by carbon tetrachloride in mice. Toxicol. Appl. Pharmacol. 172, 44-51 (2001).
247. S. Mochida, I. Ogata, Y. Ohta, S. Yamada and K. Fujiwara, In situ evaluation of the stimulatory state of hepatic macrophages based on their ability to produce superoxide anions in rats. J. Pathol. 158, 67-71 (1989).
248. K. Thompson, J. Maltby, J. Fallowfield, M. McAulay, H. Millward-Sadler and N. Sheron, Interleukin-10 expression and function in experimental murine liver inflammation and fibrosis. Hepatology 28, 1597-1606 (1998).
249. D.C. Rockey and J.J. Chung, Regulation of inducible nitric oxide synthase and nitric oxide during hepatic injury and fibrogenesis. Am. J. Physiol. 273, G124-G130 (1997).
250. J. Armendariz-Borunda, H. Katai, C.M. Jones, J.M. Seyer, A.H. Kang and R. Raghow, Transforming growth factor beta gene expression is transiently enhanced at a critical stage during liver regeneration after CCl4 treatment. Lab. Invest. 69, 283-294 (1993).
251. T. Armbrust, D. Batusic, L. Xia and G. Ramadori, Early gene expression of hepatocyte growth factor in mononuclear phagocytes of rat liver after administration of carbon tetrachloride. Liver 22, 486-494 (2002).
252. O.A. Al-Shabanah, K. Alam, M.N. Nagi, A.C. Al-Rikabi and A.M. Al-Bekairi, Protective effect of aminoguanidine, a nitric oxide synthase inhibitor, against carbon tetrachloride induced hepatotoxicity in mice. Life Sci. 66, 265-270 (2000).
253. A. Bruccoleri, R. Gallucci, D.R. Germolec, P. Blackshear, P. Simeonova, R.G. Thurman and M.I. Luster, Induction of early-immediate genes by tumor necrosis factor alpha contribute to liver repair following chemical-induced hepatotoxicity. Hepatology 25, 133-141 (1997).
254. M.J. Czaja, J. Xu and E. Alt, Prevention of carbon tetrachloride-induced rat liver injury by soluble tumor necrosis factor receptor. Gastroenterology 108, 1849-1854 (1995).
255. F. Oakley, J. Mann, S. Nailard, D.E. Smart, N. Mungalsingh, C. Constandinou, S. Ali, S.J. Wilson, H. Millward-Sadler, J.P. Iredale and D.A. Mann, Nuclear factor-κB1 (p50) limits the inflammatory and fibrogenic responses to chronic injury. Am. J. Pathol. 166, 695-708 (2005).
256. S.H. Kim, H.J. Chu, D.H. Kang, G.A. Song, M. Cho, U.S. Yang, H.J. Kim and H.Y. Chung, NF-κB binding activity and cyclooxygenase-2 expression in persistent CCl4-treated rat liver injury. J. Kor. Med. Sci. 17, 193-200 (2002).
257. T.Wen, L. Guan,Y.L. Zhang and J.Y. Zhao, Dynamic changes of heme oxygenase-1 and carbon monoxide production in acute liver injury induced by carbon tetrachloride in rats. Toxicology 228, 51-57 (2006).
258. S. Szymonik-Lesiuk, G. Czechowska, M. Stryjecka-Zimmer, M. Slomka, A. Madro, K. Celinski and M. Wielosz, Catalase, superoxide dismutase and glutathione peroxidase activities in various rat tissues after carbon tetrachloride intoxication. J. Hepatobiliary Pancreat. Surg. 10, 309-315 (2003).
259. K. Nakahira, T. Takahashi, H. Shimizu, K. Maeshima, K. Uehara, H. Fujii, H. Nakatsuka, M. Yokoyama, R. Akagi and K. Morita, Protective role of heme oxygenase-1 induction in carbon tetrachloride-induced hepatotoxicity. Biochem. Pharmacol. 66, 1091-1105 (2003).
260. D.H. Wang, K. Ishii, L.X. Zhen and K. Taketa, Enhanced liver injury in acatalasemic mice following exposure to carbon tetrachloride. Arch. Toxicol. 70, 189-194 (1996).
261. T. Armbrust and G. Ramadori, Mononuclear phagocytes of acutely injured rat liver abundantly synthesize and secrete fibronectin in contrast toKupffer cells of normal liver. Biochem. Biophys. Res. Commun. 213, 752-758 (1995).
262. T. Armbrust, M. Kreissig, K. Tron and G. Ramadori, Modulation of fibronectin gene expression in inflammatory mononuclear phagocytes of rat liver after acute liver injury. J. Hepatol. 40, 638-645 (2004).
263. J.S. Duffield, S.J. Forbes, C.M. Constandinou, S. Clay, M. Partolina, S. Vuthoori, S. Wu, R. Lang and J.P. Iredale, Selective depletion of macrophages reveals distinct, opposing roles during liver injury and repair. J. Clin. Invest. 115, 56-65 (2005).
264. N. Nieto, J.A. Dominguez-Rosales, L. Fontana, A. Salazar, J. Armendariz-Borunda, P. Greenwel and M. Rojkind, Rat hepatic stellate cells contribute to the acute-phase response with increased expression of alpha1(I) and alpha1(IV) collagens, tissue inhibitor of metalloproteinase-1 and matrix-metalloproteinase-2 messenger RNAs. Hepatology 33, 597-607 (2001).
265. C. Hellerbrand, B. Stefanovic, F. Giordano, E.R. Burchardt and D.A. Brenner, The role of TGFβ1 in initiating hepatic stellate cell activation in vivo. J. Hepatol. 30, 77-87 (1999).
266. A. Geerts, J.M. Lazou, P. De Bleser and E. Wisse, Tissue distribution, quantitation and proliferation kinetics of fat-storing cells in carbon tetrachloride-injured rat liver. Hepatology 13, 1193-1202 (1991).
267. D.E. Smart, K.J. Vincent, M.J. Arthur, O. Eickelberg, M. Castellazzi, J. Mann and D.A. Mann, JunD regulates transcription of the tissue inhibitor of metalloproteinases-1 and interleukin-6 genes in activated hepatic stellate cells. J. Biol. Chem. 276, 24414-24421 (2001).
268. J.A. Weiner, A. Chen and B.H. Davis, E-box-binding repressor is down-regulated in hepatic stellate cells during up-regulation of mannose 6-phosphate/insulin-like growth factor-II receptor expression in early hepatic fibrogenesis. J. Biol. Chem. 273, 15913-15919 (1998).
269. K.S. Lee, M. Buck, K. Houglum and M. Chojkier, Activation of hepatic stellate cells by TGF alpha and collagen type I is mediated by oxidative stress through c-myb expression. J. Clin. Invest. 96, 2461-2468 (1995).
270. S.L. Friedman, Molecular regulation of hepatic fibrosis, an integrated cellular response to tissue injury. J. Biol. Chem. 275, 2247-2250 (2000).
271. J. Kanta, S. Dooley, B. Delvoux, S. Breuer, T. D'Amico and A.M. Gressner, Tropoelastin expression is up-regulated during activation of hepatic stellate cells and in the livers of CCl4- cirrhotic rats. Liver 22, 220-227 (2002).
272. H. Yoshiji, S. Kuriyama, J. Yoshii, Y. Ikenaka, R. Noguchi, T. Nakatani, H. Tsujinoue, K. Yanase, T. Namisaki, H. Imazu and H. Fukui, Tissue inhibitor of metalloproteinases-1 attenuates spontaneous liver fibrosis resolution in the transgenic mouse. Hepatology 36, 850-860 (2002).
273. T. Kohashi, Y. Tateaki, C. Tateno, T. Asahara, M. Obara and K. Yoshizato, Expression of pleiotrophin in hepatic nonparenchymal cells and preneoplastic nodules in carbon tetrachlorideinduced fibrotic rat liver. Growth Factors 20, 53-60 (2002).
274. D.C. Rockey, C.N. Housset and S.L. Friedman, Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. J. Clin. Invest. 92, 1795-1804 (1993).
275. D.C. Rockey, The cellular pathogenesis of portal hypertension: stellate cell contractility, endothelin, and nitric oxide. Hepatology 25, 2-5 (1997).
276. D.C. Rockey and J.J. Chung, Inducible nitric oxide synthase in rat hepatic lipocytes and the effect of nitric oxide on lipocyte contractility. J. Clin. Invest. 95, 1199-1206 (1995).
277. T.K. Gupta, M. Toruner and R.J. Groszmann, Intrahepatic modulation of portal pressure and its role in portal hypertension. Role of nitric oxide. Digestion 59, 413-415 (1998).
278. S.L. Friedman, Cytokines and fibrogenesis. Semin. Liver Dis. 19, 129-140 (1999).
279. H. Louis, J.L. Van Laethem,W.Wu, E. Quertinmont, C. Degraef, K. Van den Berg, A. Demols, M. Goldman, O. Le Moine, A. Geerts and J. Deviere, Interleukin-10 controls neutrophilic infiltration, hepatocyte proliferation and liver fibrosis induced by carbon tetrachloride in mice. Hepatology 28, 1607-1615 (1998).
280. B. Saile, N. Matthes, T. Knittel and G. Ramadori, Transforming growth factor beta and tumor necrosis factor alpha inhibit both apoptosis and proliferation of activated rat hepatic stellate cells. Hepatology 30, 196-202 (1999).
281. F. Oakley, N. Trim, C.M. Constandinou, W. Ye, A.M. Gray, G. Frantz, K. Hillan, T. Kendall, R.C. Benyon, D.A. Mann and J.P. Iredale, Hepatocytes express nerve growth factor during liver injury: evidence for paracrine regulation of hepatic stellate cell apoptosis. Am. J. Pathol. 163, 1849-1858 (2003).
282. H. Jaeschke and C.W. Smith, Mechanisms of neutrophil-induced parenchymal cell injury. J. Leukoc. Biol. 61, 647-653 (1997).
283. J.J. Maher, Interactions between hepatic stellate cells and the immune system. Semin. Liver Dis. 21, 417-426 (2001).
284. M.L. Bajt, A. Farhood and H. Jaeschke, Effects of CXC chemokines on neutrophil activation and sequestration in hepatic vasculature. Am. J. Physiol. Gastrointest. Liver Physiol. 281, G1188-G1195 (2001).
285. D.L. Laskin, Nonparenchymal cells and hepatotoxicity. Semin. Liver Dis. 10, 293-304 (1990).
286. M.E. Blazka, M.R. Elwellk, S.D. Holladay, R.E. Wilson and M.I. Luster, Histopathology of acetaminophen-induced liver changes: Role of interleukin 1α and tumor necrosis factor α. Toxicol. Pathol. 24, 181-189 (1996).
287. M.E. Blazka, J.L.Wilmer, S.D. Holladay, R.E.Wilson and M.I. Luster, Role of proinflammatory cytokines in acetaminophen hepatotoxicity. Toxicol. Appl. Pharmacol. 133, 43-52 (1995).
288. H. Chiu, J.A. Brittingham and D.L. Laskin, Differential induction of heme oxygenase-1 in macrophages and hepatocytes during acetaminophen-induced hepatotoxicity in the rat: effects of hemin and biliverdin. Toxicol. Appl. Pharmacol. 181, 106-115 (2002).
289. D. Nakae, K. Yamamoto, H. Yoshiji, T. Kinugasa, H. Maruyama, J.L. Farber and Y. Konishi, Liposome-encapsulated superoxide dismutase prevents liver necrosis induced by acetaminophen. Am. J. Pathol. 136, 787-795 (1990).
290. W.D. Thompson, A.S. Jack and R.S. Patrick, The possible role of macrophages in transient hepatic fibrogenesis induced by acute carbon tetrachloride injury. J. Pathol. 130, 65-73 (1980).
291. S. Camandola, M. Aragno, J.C. Cutrin, E. Tamagno, O. Danni, E. Chiarpotto, M. Parola, G. Leonarduzzi, F. Biasi and G. Poli, Liver AP-1 activation due to carbon tetrachloride is potentiated by 1,2-dibromoethane but is inhibited by alpha-tocopherol or gadolinium chloride. Free Radic. Biol. Med. 26, 1108-1116 (1999).
292. A.E. elSisi, D.L. Earnest and I.G. Sipes, Vitamin A potentiation of carbon tetrachloride hepatotoxicity: role of liver macrophages and active oxygen species. Toxicol. Appl. Pharmacol. 119, 295-301 (1993).
293. W. Chamulitrat, M.E. Blazka, S.J. Jordan, M.I. Luster and R.P. Mason, Tumor necrosis factoralpha and nitric oxide production in endotoxin-primed rats administered carbon tetrachloride. Life Sci. 57, 2273-2280 (1995).
294. A. Katz, J. Chebath, J. Friedman and M. Revel, Increased sensitivity of IL-6-deficient mice to carbon tetrachloride hepatotoxicity and protection with an IL-6 receptor-IL-6 chimera. Cytokines Cell Mol. Ther. 4, 221-227 (1998).
295. I.G. Sipes, A.E. el Sisi,W.W. Sim, S.A. Mobley and D.L. Earnest, Reactive oxygen species in the progression of CCl4-induced liver injury. Adv. Exp. Med. Biol. 283, 489-497 (1991).
296. W. Zhu and P.C. Fung, The roles played by crucial free radicals like lipid free radicals, nitric oxide and enzymes NOS and NADPH in CCl4-induced acute liver injury of mice. Free Radic. Biol. Med. 29, 870-880 (2000).
297. C.A. Kawser, J.P. Iredale, P.J. Winwood and M.J. Arthur, Rat hepatic stellate cell expression of alpha2-macroglobulin is a feature of cellular activation: implications for matrix remodelling in hepatic fibrosis. Clin. Sci. (London) 95, 179-186 (1998).
298. J.P. Iredale, Matrix turnover in fibrogenesis. Hepatogastroenterology 43, 56-71 (1996).
299. J.P. Iredale, R.C. Benyon, M.J. Arthur, W.F. Ferris, R. Alcolado, P.J. Winwood, N. Clark and G. Murphy, Tissue inhibitor of metalloproteinase-1 messenger RNA expression is enhanced relative to interstitial collagenase messenger RNA in experimental liver injury and fibrosis. Hepatology 24, 176-184 (1996).
300. J.P. Iredale, R.C. Benyon, J. Pickering, M. McCullen, M. Northrop, S. Pawley, C. Hovell and M.J. Arthur, Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. J. Clin. Invest. 102, 538-549 (1998).